Effect of oral vitamin E and C therapy on calcineurin inhibitor levels in heart transplant recipients

Journal of Heart and Lung Transplantation

Volumn 24, Issue 8, 2005, Pages 990-994

  Lake, Kathleen D ^a   Aaronson, Keith D ^a   Gorman, Laura E ^a   Pagani, Francis D ^a   Koelling, Todd M ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b 0271 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; AGED; ANTIOXIDANT ACTIVITY; AWARENESS; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; FREQUENCY ANALYSIS; HEART TRANSPLANTATION; HUMAN; MALE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; STATISTICAL SIGNIFICANCE; VITAMIN SUPPLEMENTATION;

EID: 23744487904     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2004.06.001     Document Type: Article

References (19)

1. J.C. Fang, S. Kinlay, J. Beltrame Effect of vitamins C and E on progression of transplant-associated arteriosclerosis a randomised trial Lancet 359 2002 1108 1113
2. M.E. Billingham, N.R. Cary, M.E. Hammond A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection Heart rejection study group. The International Society for Heart and Lung Transplantation J Heart Transplant 9 1990 587 593
3. M. Frigerio, E. Bonacina, E. Gronda A semiquantitative approach to the evaluation of acute cardiac allograft rejection at endomyocardial biopsy J Heart Lung Transplant 16 1997 1087 1098
4. R. Seifeldin Drug interactions in transplantation Clin Ther 17 1995 1043 1061
5. C. Campana, M.B. Regazzi, I. Buggia, M. Molinaro Clinically significant drug interactions with cyclosporin. An update Clin Pharmacokinet 30 1996 141 179
6. P.R. Patton, M.E. Brunson, W.W. Pfaff A preliminary report of diltiazem and ketoconazole. Their cyclosporine-sparing effect and impact on transplant outcome Transplantation 57 1994 889 892
7. M.A. Masri, V. Shakuntala, M. Shanwaz Pharmacokinetics of cyclosporine in renal transplant patients on diltiazem Transplant Proc 26 1994 1921
8. G.C. Kane, J.J. Lipsky Drug-grapefruit juice interactions Mayo Clin Proc 75 2000 933 942
9. L.N. Chan Drug-nutrient interactions in transplant recipients J Parenter Enteral Nutr 25 2001 132 141
10. C. Moschella, B.L. Jaber Interaction between cyclosporine and hypericum perforatum (St. John's Wort) after organ transplantation Am J Kidney Dis 38 2001 1105 1107
11. J.A. Kobashigawa, S. Katznelson, H. Laks Effect of pravastatin on outcomes after cardiac transplantation New Engl J Med 333 1995 621 627
12. D. Andres, M. Cascales Novel mechanism of vitamin E protection against cyclosporine A cytotoxicity in cultured rat hepatocytes Biochem Pharmacol 64 2002 267 276
13. C. Wang, A.K. Salahudeen Lipid peroxidation accompanies cyclosporine nephrotoxicity effects of vitamin E Kidney Int 47 1995 927 934
14. P. Barany, P. Stenvinkel, A. Ottosson-Seeberger Effect of 6 weeks of vitamin E administration on renal haemodynamic alterations following a single dose of Neoral in healthy volunteers Nephrol Dial Transplant 16 2001 580 584
15. J.P. Boudreaux, D.H. Hayes, S. Mizrahi, P. Maggiore, J. Blazek, D. Dick Use of water-soluble liquid vitamin E to enhance cyclosporine absorption in children after liver transplant Transplant Proc 25 1993 1875
16. T. Chang, L.Z. Benet, M.F. Hebert The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers Clin Pharmacol Ther 59 1996 297 303
17. L.E. Rikans, C.R. Smith, V.G. Zannoni Ascorbic acid and cytochrome p-450 J Pharmacol Exp Ther 204 1978 702 713
18. A. Nagyova, E. Ginter The influence of ascorbic acid on the hepatic cytochrome p-450, and glutathione in guinea pigs exposed to 2,4-dichlorophenol Physiol Res 44 1995 301 305
19. K. Takahashi, Y. Akiba, K. Tamura Effect of dietary ascorbic acid on the hepatic microsomal mixed function oxidase system in liver of chicks treated with Escherichia coli lipopolysaccharide Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 118 1997 301 304